CLL1-TDB

N/A

Report date: 2026/03/19 16:59:36

Base Information

Drug NameCLL1-TDB

Drug Alias NameCD3/CLL1 (TDB)anti-CD3/anti-CLL1 bispecific T-cell engager (Genentech)CLL1-TDB

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionC-Type lectin domain family 12 member A modulatorsT cell surface glycoprotein CD3 modulators

TargetsT cell surface glycoprotein CD3C-Type lectin domain family 12 member A

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A